Skip to main content

Silvia Ferrer López

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Silvia Ferrer López

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Mireya Torres Moliner

Mireya Torres Moliner

Predoctoral researcher
Growth and Development
Read more
Beatriz Gracia Lillo

Beatriz Gracia Lillo

Research technician
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more
Laia Rubio Ortega

Laia Rubio Ortega

Research technician
Gene Therapy at Nervous System
Read more
Maria Carme Altadill Sanchez

Maria Carme Altadill Sanchez

Research assistant
Biomedical Research in Urology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.